Lotrich, Francis E.

Inflammatory cytokine-associated depression

Lotrich, F. E. (2015) · Brain Research

Tryptophan and brain disordersStress Responses and Cortisol

Cited by 183

Cytokine-induced depression during IFN-α treatment: The role of IL-6 and sleep quality

Prather, A. A., Rabinovitz, M., Pollock, B. G., & Lotrich, F. E. (2009) · Brain Behavior and Immunity

Tryptophan and brain disordersTreatment of Major Depression

Cited by 139

Plasma biosignature and brain pathology related to persistent cognitive impairment in late-life depression

Diniz, B. S., Sibille, E., Ding, Y., Tseng, G., Aizenstein, H. J., Lotrich, F., Becker, J. T., Lopez, O. L., Lotze, M. T., Klunk, W. E., et al. (2015) · Molecular Psychiatry

Dementia and Cognitive Impairment ResearchTreatment of Major Depression

Cited by 116

Depression following pegylated interferon-alpha: Characteristics and vulnerability

Lotrich, F. E., Rabinovitz, M., Gironda, P., & Pollock, B. G. (2007) · Journal of Psychosomatic Research

Tryptophan and brain disordersHepatitis C virus research

Cited by 100

Brain-Derived Neurotrophic Factor Serum Levels and Genotype: Association with Depression during Interferon-α Treatment

Lotrich, F. E., Albusaysi, S., & Ferrell, R. E. (2013) · Neuropsychopharmacology

Tryptophan and brain disordersTreatment of Major Depression

Cited by 92

Enhanced Molecular Aging in Late-Life Depression: the Senescent-Associated Secretory Phenotype

Diniz, B. S., Reynolds, C. F., Sibille, E., Lin, C.-W., Tseng, G., Lotrich, F., Aizenstein, H. J., & Butters, M. A. (2017) · The American Journal of Geriatric Psychiatry

Telomeres, Telomerase, and SenescenceGenetics, Aging, and Longevity in Model Organisms

Cited by 73

Antidepressant response trajectories and associated clinical prognostic factors among older adults

Smagula, S. F., Butters, M. A., Anderson, S. J., Lenze, E. J., Dew, M. A., Mulsant, B. H., Lotrich, F. E., Aizenstein, H., & Reynolds, C. F. (2015) · JAMA Psychiatry

Treatment of Major DepressionAnxiety, Depression, Psychometrics, Treatment, Cognitive Processes

Cited by 71

Poor sleep quality predicts onset of either major depression or subsyndromal depression with irritability during interferon-alpha treatment

Franzen, P. L., Buysse, D. J., Rabinovitz, M., Pollock, B. G., & Lotrich, F. E. (2010) · Psychiatry Research

Sleep and related disordersHepatitis C virus research

Cited by 62

Predicting 6-week treatment response to escitalopram pharmacotherapy in late-life major depressive disorder

Saghafi, R., Brown, C., Butters, M. A., Cyranowski, J., Dew, M. A., Frank, E., Gildengers, A., Karp, J. F., Lenze, E. J., Lotrich, F., et al. (2007) · International Journal of Geriatric Psychiatry

Treatment of Major DepressionAnxiety, Depression, Psychometrics, Treatment, Cognitive Processes

Cited by 47

Effect of 2 Psychotherapies on Depression and Disease Activity in Pediatric Crohnʼs Disease

Szigethy, E., Youk, A. O., Gonzalez-Heydrich, J., Bujoreanu, S. I., Weisz, J., Fairclough, D., Ducharme, P., Jones, N., Lotrich, F., Keljo, D., et al. (2015) · Inflammatory Bowel Diseases

Inflammatory Bowel DiseaseAnxiety, Depression, Psychometrics, Treatment, Cognitive Processes

Cited by 34

Escitalopram reduces attentional performance in anxious older adults with high-expression genetic variants at serotonin 2A and 1B receptors

Lenze, E. J., Dixon, D., Nowotny, P., Lotrich, F. E., Doré, P. M., Pollock, B. G., Hinrichs, A. L., & Butters, M. A. (2013) · International Journal of Neuropsychopharmacology

Neurotransmitter Receptor Influence on BehaviorPharmacogenetics and Drug Metabolism

Cited by 23